PFF Borrow Costs Spike as Shorts Quietly Rebuild
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
PFF — the iShares Preferred and Income Securities ETF — enters August with a curious internal tension: the stock has drifted gently higher while its borrow market has quietly tightened and short interest has rebounded sharply off multi-month lows.
The most striking data point this week is not the price. Cost to borrow has jumped 21% over the past week to 2.13%, after spending most of July collapsing from an extraordinary one-day spike of 32.2% on July 1 — a reading that dwarfs anything else visible in the 30-day history. That July 1 anomaly has faded, but the directional trend since mid-July is clearly back toward tighter borrow conditions. The cost hit a trough near 1.30% on July 27 and has climbed steadily since, suggesting renewed demand for the short side.
Short interest tells a more nuanced story here. At 1.04% of the free float, the short position is modest by any standard — this is not a heavily contested ETF. But the week-on-week move is notable: short shares rose nearly 10% over the past week to around 4.76 million, reversing a sustained unwind from late June when short interest ran above 10 million shares. The full picture from the 30-day history is striking — SI more than halved over a single month, falling from roughly 10.7 million shares on June 30 to a trough near 3.9 million on July 29, before rebuilding this week. Shorts appear to have exited aggressively through July and are now modestly re-engaging. Availability, at 141.5% of short interest, remains healthy — there is no squeeze pressure developing — and the 52-week low availability reading of just 0.49% (from earlier in the year) is a distant memory for now.
Options positioning adds a layer of context. PFF options traders have maintained a persistently heavy put bias — the put/call ratio is running at 2.03, close to its 20-day average of 1.97 and well above what you would typically see on an equity index ETF. The z-score is a modest 0.36, meaning this is not an unusual reading relative to recent history; rather, the consistently elevated ratio reflects the structural character of PFF's options market, where income-oriented holders routinely buy downside protection. The 52-week range on PCR spans 0.62 to 2.84, so the current reading lands in the middle — cautious but not alarmist.
The income angle remains the fundamental anchor for this ETF. Monthly dividends have been arriving with consistency: the most recent payment of $0.142 per share on August 3 continues a run of five consecutive monthly distributions hovering between $0.138 and $0.142, implying an annualised yield close to 5.5% on the current price of $30.73. That income stream is the reason the holder base skews heavily toward wealth managers and advisory channels — Morgan Stanley, Merrill Lynch, Wells Fargo, and LPL Financial collectively represent the largest disclosed positions, with none holding more than 3.2% of shares. The ownership profile is fragmented and income-driven, not tactical. BlackRock added 338,284 shares in the quarter to June 30, a modest but notable increase from the sponsor's own related asset management arm.
What to watch next is the trajectory of the borrow cost and whether the short rebuild continues — if June's episode of near-zero availability and a briefly spiked CTB of 32% has any structural echo, the path from "normal" back toward "constrained" lending conditions is worth tracking against the backdrop of financial-sector preferred issuance and any movement in longer-dated rates.
Stocks in this article
See the live data behind this article on ORTEX.
Open PFF on ORTEX →How this article was generated
- Generated
- 5 Aug 2026, 19:03
- Data as of
- 5 Aug 2026, 19:02
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notes
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.